Dr Lindsay Rein comments on significant advancements in CML treatment presented at ASH 2024, particularly the approval of asciminib in both the frontline and second-line settings. This new treatment ...

A cohort study identified a link between COVID-19 and a faster decline in kidney function, especially following ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...

Drinking coffee is associated with the abundance of the gut bacterium Lawsonibacter asaccharolyticus, demonstrating that ...

An analysis of 6000 cardiac reoperations revealed timing between surgeries did not generally affect operative mortality, ...

Long COVID appears to be more prevalent in young and middle-aged adults and may not be taken as seriously as in other age ...

Women with metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men ...

Recombinant pertussis booster vaccines provided sustained immunity against whooping cough in adolescents and young adults, ...

The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often ...

Oxygen therapy saves lives, but does it improve quality of life? Dr Holley explores the balance of benefits, burdens, and ...

Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...